Benchmarks for the assessment of novel cardiovascular biomarkers
10.1161/circulationaha.106.683110 · doi-reference
10.3389/fgene.2017.00084
10.3389/fgene.2017.00084 · doi-reference
10.3390/cancers11020155
10.3390/cancers11020155 · doi-reference
Bioinformatics tools and workflow to select blood biomarkers for early cancer diagnosis: an application to pancreatic cancer
10.1002/pmic.201800489 · doi-reference
10.1016/j.ccell.2017.07.007
10.1016/j.ccell.2017.07.007 · doi-reference
10.1093/bib/bbw114
10.1093/bib/bbw114 · doi-reference
10.1016/j.ebiom.2019.03.056
10.1016/j.ebiom.2019.03.056 · doi-reference
A panel of three biomarkers identified by iTRAQ for the early diagnosis of pancreatic cancer
10.1002/prca.201800195 · doi-reference
10.1093/jnci/djw341
10.1093/jnci/djw341 · doi-reference
A new panel of pancreatic cancer biomarkers discovered using a mass spectrometry-based pipeline
10.1038/bjc.2017.365 · doi-reference
Diagnostic performance enhancement of pancreatic cancer using proteomic multimarker panel
10.18632/oncotarget.21861 · doi-reference
Large-scale clinical validation of biomarkers for pancreatic cancer using a mass spectrometry-based proteomics approach
10.18632/oncotarget.17463 · doi-reference
10.1371/journal.pone.0161009
10.1371/journal.pone.0161009 · doi-reference
Neutrophil Gelatinase-Associated Lipocalin (NGAL) concentration in urine is superior to CA19-9 and Ca 125 in differentiation of pancreatic mass: Preliminary report
10.3233/cbm-160595 · doi-reference
10.1158/1078-0432.ccr-14-2467
10.1158/1078-0432.ccr-14-2467 · doi-reference
Levels of soluble LR11/SorLA are highly increased in the bile of patients with biliary tract and pancreatic cancers
10.1016/j.cca.2016.04.010 · doi-reference
Bile proteomics for differentiation of malignant from benign biliary strictures: a pilot study
10.1093/gastro/gou066 · doi-reference
10.1002/pmic.201400476
10.1002/pmic.201400476 · doi-reference
10.1097/mpa.0000000000000931
10.1097/mpa.0000000000000931 · doi-reference
10.1002/cam4.2340
10.1002/cam4.2340 · doi-reference
Highly accurate identification of cystic precursor lesions of pancreatic cancer through targeted mass spectrometry: a phase IIc diagnostic study
10.1200/jco.2017.73.7288 · doi-reference
Metabolomics identifies serum and exosomes metabolite markers of pancreatic cancer
10.1007/s11306-019-1550-1 · doi-reference
Label-free characterization of exosome via surface enhanced Raman spectroscopy for the early detection of pancreatic cancer
10.1016/j.nano.2018.11.008 · doi-reference
10.1021/acsnano.7b08199
10.1021/acsnano.7b08199 · doi-reference
10.1038/nature14581
10.1038/nature14581 · doi-reference
Q & A: what are exosomes, exactly?
10.1186/s12915-016-0268-z · doi-reference
10.1021/pr5002719
10.1021/pr5002719 · doi-reference
Macrophage inhibitory cytokine 1 (MIC-1/GDF15) as a novel diagnostic serum biomarker in pancreatic ductal adenocarcinoma
10.1186/1471-2407-14-578 · doi-reference
Plasma interleukin-11 (IL-11) levels have diagnostic and prognostic roles in patients with pancreatic cancer
10.1007/s13277-014-2459-y · doi-reference
Challenges and opportunities in cancer metabolomics
10.1002/pmic.201900042 · doi-reference
The metabolic time line of pancreatic cancer: Opportunities to improve early detection of adenocarcinoma
10.1016/j.amjsurg.2019.08.015 · doi-reference
10.18632/oncotarget.25212
10.18632/oncotarget.25212 · doi-reference
A novel serum metabolomics-based diagnostic approach to pancreatic cancer
10.1158/1055-9965.epi-12-1033 · doi-reference
Pancreatic cancer screening using a multiplatform human serum metabolomics system
10.2217/bmm-2016-0020 · doi-reference
Identification of highly sensitive biomarkers that can aid the early detection of pancreatic cancer using GC/MS/MS-based targeted metabolomics
10.1016/j.cca.2017.02.011 · doi-reference
Metabonomics
10.1038/4551054a · doi-reference
10.1126/scitranslmed.aah5583
10.1126/scitranslmed.aah5583 · doi-reference
A combination of MUC5AC and CA19-9 improves the diagnosis of pancreatic cancer: a multicenter study:
10.1038/ajg.2016.482 · doi-reference
10.1093/jnci/djw266
10.1093/jnci/djw266 · doi-reference
Identification of serum biomarker panels for the early detection of pancreatic cancer
10.1158/1055-9965.epi-18-0483 · doi-reference
